Cargando…

Prolactin related symptoms during risperidone maintenance treatment: results from a prospective, multicenter study of schizophrenia

BACKGROUND: This study aimed to investigate prolactin related symptoms (PRS) in individuals with schizophrenia during risperidone maintenance treatment for one year, as well as to identify the risk factors for PRS. METHODS: In a multicenter, randomized, controlled, longitudinal study, clinically sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bo, Qijing, Dong, Fang, Li, Xianbin, Wang, Zhimin, Ma, Xin, Wang, Chuanyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103401/ https://www.ncbi.nlm.nih.gov/pubmed/27829454 http://dx.doi.org/10.1186/s12888-016-1103-3

Ejemplares similares

F57. CORRELATION FACTORS OF ABNORMAL MENSES IN SCHIZOPHRENIA TREATMENT WITH RISPERIDONE
por: Dong, Fang, et al.
Publicado: (2018)

S15. ABNORMAL EYE TRACKING IN PATIENTS WITH SCHIZOPHRENIA UNDER THE SOCIAL SCENE
por: Bo, Qijing, et al.
Publicado: (2018)

Use of the MATRICS consensus cognitive battery (MCCB) to evaluate cognitive deficits in bipolar disorder: A systematic review and meta-analysis
por: Bo, Qijing, et al.
Publicado: (2017)

T37. PREPULSE INHIBITION IN UNAFFECTED SIBLINGS OF SCHIZOPHRENIA AND CLINICAL-HIGH RISK WITHOUT FAMILY HISTORY OF PSYCHOSIS
por: Zhen, Mao, et al.
Publicado: (2020)

Audit on prolactin monitoring for patients on oral risperidone, intramuscular risperidone, and intramuscular paliperidone
por: Bader, Mohamed
Publicado: (2021)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

RISPERIDONE IN SCHIZOPHRENIA
por: Kumar, P.N. Suresh
Publicado: (1999)

Comparative study of sexual dysfunction and serum prolactin level associated with olanzapine, risperidone, and clozapine in patients with remitted schizophrenia
por: Sathish Kumar, S. V., et al.
Publicado: (2015)

Prepulse inhibition in patients with bipolar disorder: a systematic review and meta-analysis
por: Mao, Zhen, et al.
Publicado: (2019)

S72. MCCB COGNITIVE PROFILE IN CHINESE FIRST EPISODE SCHIZOPHRENIA PATIENTS AND SUBJECTS AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Lei, Zhao, et al.
Publicado: (2020)

Quality of life and its predictors in first-episode schizophrenia and individuals at clinical high-risk for psychosis
por: Mao, Zhen, et al.
Publicado: (2023)

REEMERGENCE OF POSITIVE SYMPTOMS OF SCHIZOPHRENIA DURING THE COURSE OF TREATMENT WITH RISPERIDONE
por: Bajaj, Priya, et al.
Publicado: (1999)

Quality of life in euthymic patients with unipolar major depressive disorder and bipolar disorder
por: Bo, Qijing, et al.
Publicado: (2019)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Duggal, Harpreet S., et al.
Publicado: (1999)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Agarwal, A.K., et al.
Publicado: (1998)

Core of sensory gating deficits in first-episode schizophrenia: attention dysfunction
por: Ding, Yushen, et al.
Publicado: (2023)

RE-EMERGENCE OF POSITIVE SYMPTOMS OF SCHIZOPHRENIA DURING THE COURSE OF TREATMENT WITH RISPERIDONE
por: Sivaprakash, B., et al.
Publicado: (1999)

Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents
por: Margari, Lucia, et al.
Publicado: (2015)

Comparison of risperidone, olanzapine and quetiapine: effects on body weight, serum blood glucose and prolactin
por: Chaudhry, Haroon Rashid, et al.
Publicado: (2008)

Brain-Specific Oxysterols and Risk of Schizophrenia in Clinical High-Risk Subjects and Patients With Schizophrenia
por: Sun, Zuoli, et al.
Publicado: (2021)

An open-label, multicenter evaluation of the long-term safety and efficacy of risperidone in adolescents with schizophrenia
por: Pandina, Gahan, et al.
Publicado: (2012)

Speech-on-speech masking and psychotic symptoms in schizophrenia
por: Wu, Chao, et al.
Publicado: (2018)

ONCE DAILY RISPERIDONE IN TREATMENT OF SCHIZOPHRENIA
por: Agarwal, Vivek, et al.
Publicado: (2001)

COMPARATIVE EFFICACY OF CENTBUTINDOLE & RISPERIDONE IN SCHIZOPHRENIA
por: Chandra, R., et al.
Publicado: (2002)

Risperidone Associated Paralytic Ileus in Schizophrenia
por: Ramamourthy, Parthasarathy, et al.
Publicado: (2013)

Olanzapine has better efficacy compared to risperidone for treatment of negative symptoms in schizophrenia
por: Suresh Kumar, P. N., et al.
Publicado: (2016)

Olanzapine has poorer efficacy than risperidone for the treatment of the negative symptoms of schizophrenia
por: Vadlamani, Laxmi Naresh, et al.
Publicado: (2017)

Obesity, antioxidants and negative symptom improvement in first-episode schizophrenia patients treated with risperidone
por: Gao, Zhiyong, et al.
Publicado: (2023)

Randomized controlled trial comparing changes in serum prolactin and weight among female patients with first-episode schizophrenia over 12 months of treatment with risperidone or quetiapine
por: LIU, Jianjun, et al.
Publicado: (2014)

Pharmacogenomics Factors Influencing the Effect of Risperidone on Prolactin Levels in Thai Pediatric Patients With Autism Spectrum Disorder
por: Hongkaew, Yaowaluck, et al.
Publicado: (2021)

Clinical utility of the risperidone formulations in the management of schizophrenia
por: Madaan, Vishal, et al.
Publicado: (2011)

Prolactin and Family Psychiatric History in Schizophrenia
por: Bouguerra, I., et al.
Publicado: (2023)

Methylome-wide association study of different responses to risperidone in schizophrenia
por: Du, Huihui, et al.
Publicado: (2022)

Risperidone improves interpersonal perception and executive function in patients with schizophrenia
por: Zhou, Zhenhe, et al.
Publicado: (2016)

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
por: Alphs, Larry, et al.
Publicado: (2013)

The Therapeutic Effectiveness of Risperidone on Negative Symptoms of Schizophrenia in Comparison with Haloperidol: A Randomized Clinical Trial
por: Mirabzadeh, Arash, et al.
Publicado: (2014)

Different responses to risperidone treatment in Schizophrenia: a multicenter genome-wide association and whole exome sequencing joint study
por: Zhao, Mingzhe, et al.
Publicado: (2022)

Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone
por: Olfson, Mark, et al.
Publicado: (2007)

Efficacy of Risperidone Orally Disintegrating Tablets Combined with Oxazepam in the Treatment of Schizophrenia
por: Fang, Liang, et al.
Publicado: (2022)

The reliability and validity of PHQ-9 in patients with major depressive disorder in psychiatric hospital
por: Sun, Yue, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rdei065fjamd9h2rgkipb512e3